Economic evaluation of the levonorgestrel-releasing intrauterine system for the treatment of dysfunctional uterine bleeding in Spain
Open Access
- 1 January 2011
- journal article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 154 (1) , 71-80
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The levonorgestrel intrauterine system (Mirena®) for treatment of idiopathic menorrhagia. Assessment of quality of life and satisfactionThe European Journal of Contraception & Reproductive Health Care, 2008
- Cost-effectiveness of treatments for dysfunctional uterine bleeding in women who need contraceptionContraception, 2006
- Hormonal Management of Abnormal Uterine BleedingClinical Obstetrics and Gynecology, 2005
- Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resectionFertility and Sterility, 2001
- Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysisContraception, 2001
- Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trialThe Lancet, 2001
- Handling Uncertainty in Cost-Effectiveness ModelsPharmacoEconomics, 2000
- A Cost-Utility Analysis of Abdominal Hysterectomy Versus Transcervical Endometrial Resection for the Surgical Treatment of MenorrhagiaInternational Journal of Technology Assessment in Health Care, 1998
- Endometrial resection versus vaginal hysterectomy for menorrhagia: Long-term clinical and quality-of-life outcomesAmerican Journal of Obstetrics and Gynecology, 1997
- Randomized Trial of 2 Hormonal and 2 Prostaglandin‐inhibiting Agents in Women with a Complaint of MenorrhagiaAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1991